These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 18505352)
1. Overview of the findings from the European SOHO study. Suarez D; Haro JM Expert Rev Neurother; 2008 Jun; 8(6):873-80. PubMed ID: 18505352 [TBL] [Abstract][Full Text] [Related]
2. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia. Haro JM; Salvador-Carulla L CNS Drugs; 2006; 20(4):293-301. PubMed ID: 16599647 [TBL] [Abstract][Full Text] [Related]
3. [The intercontinental schizophrenia outpatient health outcomes study (IC-SOHO): initial 6 month findings of the sample in Latin America]. Brunner E; Gargoloff P; Caro O; González C; Landa E; González CH; Barahona A; Soria D; Tamayo J; Rovner J; Adrianzen C; Silva H; Hodge A; O'Halloran R; Assunção SS; Actas Esp Psiquiatr; 2006; 34(1):16-27. PubMed ID: 16525901 [TBL] [Abstract][Full Text] [Related]
4. Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study. Novick D; Bousono M; Suarez D; Olivares JM; Montejo AL; Haro JM; Edgell ET; Ratcliffe M; Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):972-82. PubMed ID: 16023776 [TBL] [Abstract][Full Text] [Related]
5. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results. Haro JM; Suarez D; Novick D; Brown J; Usall J; Naber D; Eur Neuropsychopharmacol; 2007 Mar; 17(4):235-44. PubMed ID: 17137759 [TBL] [Abstract][Full Text] [Related]
6. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients. Karagianis J; Novick D; Pecenak J; Haro JM; Dossenbach M; Treuer T; Montgomery W; Walton R; Lowry AJ Int J Clin Pract; 2009 Nov; 63(11):1578-88. PubMed ID: 19780867 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Bitter I; Treuer T; Dyachkova Y; Martenyi F; McBride M; Ungvari GS Eur Neuropsychopharmacol; 2008 Mar; 18(3):170-80. PubMed ID: 17884390 [TBL] [Abstract][Full Text] [Related]
9. Meeting everyday challenges: antipsychotic therapy in the real world. Gorwood P Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S156-62. PubMed ID: 16872807 [TBL] [Abstract][Full Text] [Related]
10. [The European schizophrenia outpatient health outcomes (SOHO) study: baseline findings of the Spanish sample]. Ciudad A; Prieto L; Olivares JM; Montejo AL; Ros S; Novick D; Actas Esp Psiquiatr; 2004; 32(4):227-35. PubMed ID: 15232752 [TBL] [Abstract][Full Text] [Related]
11. Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Novick D; Haro JM; Perrin E; Suarez D; Texeira JM Eur Neuropsychopharmacol; 2009 Aug; 19(8):542-50. PubMed ID: 19500949 [TBL] [Abstract][Full Text] [Related]
12. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Novick D; Haro JM; Suarez D; Perez V; Dittmann RW; Haddad PM Psychiatry Res; 2010 Apr; 176(2-3):109-13. PubMed ID: 20185182 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Haro JM; Edgell ET; Novick D; Alonso J; Kennedy L; Jones PB; Ratcliffe M; Breier A; Acta Psychiatr Scand; 2005 Mar; 111(3):220-31. PubMed ID: 15701107 [TBL] [Abstract][Full Text] [Related]
15. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial. Nasrallah HA J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients. Høiberg MP; Nielsen B Nord J Psychiatry; 2006; 60(3):207-12. PubMed ID: 16720511 [TBL] [Abstract][Full Text] [Related]
19. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study. Haro JM; Novick D; Suarez D; Alonso J; Lépine JP; Ratcliffe M; J Clin Psychopharmacol; 2006 Dec; 26(6):571-8. PubMed ID: 17110813 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia. Obradovic M; Mrhar A; Kos M Int J Clin Pract; 2007 Dec; 61(12):1979-88. PubMed ID: 17997804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]